Current Approaches To Disease Modification

Simon Stott introduces “disease modification” and sets out the directions the research community is taking to tackle Parkinson’s along with the related drug trials.  His presentation is followed by a Q&A Panel. The questions addressed genetic research and its applicability to the idiopathic diagnosis, the impact of Covid-19, and when new treatments could be available.